国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Xenopus tropicalis C2 domain-containing protein 3 (c2cd3), partial CSB-YP003826XBF
CSB-EP003826XBF
CSB-BP003826XBF
CSB-MP003826XBF
CSB-EP003826XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis CUGBP Elav-like family member 5 (celf5) CSB-YP002824XBF
CSB-EP002824XBF
CSB-BP002824XBF
CSB-MP002824XBF
CSB-EP002824XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis BRCA1-A complex subunit RAP80 (uimc1), partial CSB-YP025608XBF
CSB-EP025608XBF
CSB-BP025608XBF
CSB-MP025608XBF
CSB-EP025608XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Ras-GEF domain-containing family member 1A (rasgef1a) CSB-YP019357XBF
CSB-EP019357XBF
CSB-BP019357XBF
CSB-MP019357XBF
CSB-EP019357XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Activating transcription factor 7-interacting protein 1 (atf7ip), partial CSB-YP002280DIL
CSB-EP002280DIL
CSB-BP002280DIL
CSB-MP002280DIL
CSB-EP002280DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Transcription factor RFX3 (rfx3), partial CSB-YP019612DIL
CSB-EP019612DIL
CSB-BP019612DIL
CSB-MP019612DIL
CSB-EP019612DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Aspartate beta-hydroxylase domain-containing protein 2 (asphd2), partial CSB-YP002228DIL1
CSB-EP002228DIL1
CSB-BP002228DIL1
CSB-MP002228DIL1
CSB-EP002228DIL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Bicaudal D-related protein 2 (ccdc64b) CSB-YP004726DIL
CSB-EP004726DIL
CSB-BP004726DIL
CSB-MP004726DIL
CSB-EP004726DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Ribosome biogenesis protein bop1 (bop1), partial CSB-YP002779DIL
CSB-EP002779DIL
CSB-BP002779DIL
CSB-MP002779DIL
CSB-EP002779DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Histone-lysine N-methyltransferase SUV420H2 (suv420h2), partial CSB-YP022975XBE
CSB-EP022975XBE
CSB-BP022975XBE
CSB-MP022975XBE
CSB-EP022975XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Nephrocystin-3 (nphp3), partial CSB-YP015986XBF
CSB-EP015986XBF
CSB-BP015986XBF
CSB-MP015986XBF
CSB-EP015986XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Ubiquitin carboxyl-terminal hydrolase 20 (usp20), partial CSB-YP025711XBF
CSB-EP025711XBF
CSB-BP025711XBF
CSB-MP025711XBF
CSB-EP025711XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Tudor domain-containing protein 5 (tdrd5), partial CSB-YP023358XBF
CSB-EP023358XBF
CSB-BP023358XBF
CSB-MP023358XBF
CSB-EP023358XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Paired box protein Pax-8 (pax8) CSB-YP017494XBF
CSB-EP017494XBF
CSB-BP017494XBF
CSB-MP017494XBF
CSB-EP017494XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Katanin p60 ATPase-containing subunit A-like 2 (katnal2), partial CSB-YP011992XBF
CSB-EP011992XBF
CSB-BP011992XBF
CSB-MP011992XBF
CSB-EP011992XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Two pore calcium channel protein 2 (tpcn2), partial CSB-YP024095DIL
CSB-EP024095DIL
CSB-BP024095DIL
CSB-MP024095DIL
CSB-EP024095DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Myotubularin-related protein 10 (mtmr10), partial CSB-YP015175DIL
CSB-EP015175DIL
CSB-BP015175DIL
CSB-MP015175DIL
CSB-EP015175DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio HAUS augmin-like complex subunit 6 (haus6), partial CSB-YP008208DIL
CSB-EP008208DIL
CSB-BP008208DIL
CSB-MP008208DIL
CSB-EP008208DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Probable UDP-sugar transporter protein SLC35A4 (slc35a4), partial CSB-YP021586DIL
CSB-EP021586DIL
CSB-BP021586DIL
CSB-MP021586DIL
CSB-EP021586DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Myotubularin-related protein 2 (mtmr2), partial CSB-YP015180DIL
CSB-EP015180DIL
CSB-BP015180DIL
CSB-MP015180DIL
CSB-EP015180DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>